{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T10:32:22Z","timestamp":1794479542790,"version":"4.9.1"},"reference-count":40,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T00:00:00Z","timestamp":1789948800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002241","name":"Japan Science and Technology Agency","doi-asserted-by":"publisher","award":["JPMJSP2180"],"award-info":[{"award-number":["JPMJSP2180"]}],"id":[{"id":"10.13039\/501100002241","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003478","name":"Government of Japan Ministry of Health Labour and Welfare","doi-asserted-by":"publisher","award":["22FC0201"],"award-info":[{"award-number":["22FC0201"]}],"id":[{"id":"10.13039\/501100003478","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007449","name":"Takeda Science Foundation","doi-asserted-by":"publisher","award":["FY2023"],"award-info":[{"award-number":["FY2023"]}],"id":[{"id":"10.13039\/100007449","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["23fk0108671h0001"],"award-info":[{"award-number":["23fk0108671h0001"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["23fk0108672h0001"],"award-info":[{"award-number":["23fk0108672h0001"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["25K02864"],"award-info":[{"award-number":["25K02864"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP 20K09824"],"award-info":[{"award-number":["JP 20K09824"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["iScience"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.isci.2026.117775","type":"journal-article","created":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T05:37:20Z","timestamp":1791524240000},"page":"117775","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Dual impact of EZH1\/2-targeted therapy in HTLV-1-associated inflammation: Direct and indirect mechanisms"],"prefix":"10.1016","volume":"29","author":[{"given":"Yaru","family":"Zou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koju","family":"Kamoi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingming","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Zong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyoko","family":"Ohno-Matsui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.isci.2026.117775_bib1","doi-asserted-by":"crossref","first-page":"5931","DOI":"10.1038\/sj.onc.1208981","article-title":"Discovery of HTLV-1, the first human retrovirus, its unique regulatory mechanisms, and insights into pathogenesis","volume":"24","author":"Yoshida","year":"2005","journal-title":"Oncogene"},{"key":"10.1016\/j.isci.2026.117775_bib2","doi-asserted-by":"crossref","first-page":"388","DOI":"10.3389\/fmicb.2012.00388","article-title":"Epidemiological Aspects and World Distribution of HTLV-1 Infection","volume":"3","author":"Gessain","year":"2012","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.isci.2026.117775_bib3","doi-asserted-by":"crossref","DOI":"10.3390\/v14040794","article-title":"Updates on HTLV-1 Uveitis","volume":"14","author":"Kamoi","year":"2022","journal-title":"Viruses"},{"key":"10.1016\/j.isci.2026.117775_bib4","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1016\/S0140-6736(18)30974-7","article-title":"Time to eradicate HTLV-1: an open letter to WHO","volume":"391","author":"Martin","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.isci.2026.117775_bib5","series-title":"Human T-Lymphotropic Virus Type 1: Technical Report","year":"2021"},{"key":"10.1016\/j.isci.2026.117775_bib6","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.preteyeres.2012.10.002","article-title":"Immunological homeostasis of the eye","volume":"33","author":"Mochizuki","year":"2013","journal-title":"Prog. Retin. Eye Res."},{"key":"10.1016\/j.isci.2026.117775_bib7","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/s41408-023-00841-7","article-title":"Primary cells from patients with adult T cell leukemia\/lymphoma depend on HTLV-1 Tax expression for NF-\u03baB activation and survival","volume":"13","author":"Hleihel","year":"2023","journal-title":"Blood Cancer J."},{"key":"10.1016\/j.isci.2026.117775_bib8","doi-asserted-by":"crossref","first-page":"388","DOI":"10.3389\/fmicb.2020.00388","article-title":"HTLV-1 in Ophthalmology","volume":"11","author":"Kamoi","year":"2020","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.isci.2026.117775_bib9","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1080\/17469899.2023.2281446","article-title":"Current challenges facing the clinical treatment for HTLV-1 ocular manifestations","volume":"18","author":"Kamoi","year":"2023","journal-title":"Expert Rev. Ophthalmol."},{"key":"10.1016\/j.isci.2026.117775_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/S2352-3026(20)30226-X","article-title":"Frosted branch angiitis after allogeneic haematopoietic stem cell transplantation in adult T-cell leukaemia-lymphoma","volume":"7","author":"Kamoi","year":"2020","journal-title":"Lancet Haematol."},{"key":"10.1016\/j.isci.2026.117775_bib11","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/S0140-6736(21)02442-9","article-title":"HTLV-1 uveitis and Graves' disease presenting with sudden onset of blurred vision","volume":"399","author":"Kamoi","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.isci.2026.117775_bib12","doi-asserted-by":"crossref","first-page":"9874","DOI":"10.1038\/s41467-025-64836-7","article-title":"Chromatin remodeling enhances MAP3K8 expression in HAM: a key pathogenesis for therapeutic intervention","volume":"16","author":"Nakashima","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.isci.2026.117775_bib13","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1136\/bjophthalmol-2019-315675","article-title":"Tackling HTLV-1 infection in ophthalmology: a nationwide survey of ophthalmic care in an endemic country, Japan","volume":"104","author":"Kamoi","year":"2020","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.isci.2026.117775_bib14","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/S1473-3099(21)00063-3","article-title":"Horizontal transmission of HTLV-1 causing uveitis","volume":"21","author":"Kamoi","year":"2021","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.isci.2026.117775_bib15","doi-asserted-by":"crossref","DOI":"10.1002\/jmv.70000","article-title":"Sexual transmission of HTLV-1 resulting in uveitis with short-term latency and low proviral load","volume":"96","author":"Kamoi","year":"2024","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.isci.2026.117775_bib16","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1080\/09273948.2023.2175697","article-title":"Human T-cell Leukemia Virus Type 1 (HTLV-1)-induced Uveitis","volume":"31","author":"Terada","year":"2023","journal-title":"Ocul. Immunol. Inflamm."},{"key":"10.1016\/j.isci.2026.117775_bib17","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/S0002-9394(14)71279-6","article-title":"Clinical and Immunologic Features of Human T-cell Lymphotropic Virus Type I Uveitis","volume":"116","author":"Yoshimura","year":"1993","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.isci.2026.117775_bib18","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1089\/jop.2016.0124","article-title":"Human T Cell Leukemia Virus Type 1 and Eye Diseases","volume":"33","author":"Terada","year":"2017","journal-title":"J. Ocul. Pharmacol. Therapeut."},{"key":"10.1016\/j.isci.2026.117775_bib19","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1212\/CPJ.0000000000000832","article-title":"Management of HAM\/TSP: Systematic Review and Consensus-based Recommendations 2019","volume":"11","author":"Araujo","year":"2021","journal-title":"Neurol., Clin. Pract."},{"key":"10.1016\/j.isci.2026.117775_bib20","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1182\/blood.2024027902","article-title":"A phase 2 trial of CHOP with anti-CCR4 antibody mogamulizumab for older patients with adult T-cell leukemia\/lymphoma","volume":"146","author":"Yoshimitsu","year":"2025","journal-title":"Blood"},{"key":"10.1016\/j.isci.2026.117775_bib21","doi-asserted-by":"crossref","first-page":"4086","DOI":"10.1200\/JCO.2016.67.7732","article-title":"Multicenter Phase II Study of Lenalidomide in Relapsed or Recurrent Adult T-Cell Leukemia\/Lymphoma: ATLL-002","volume":"34","author":"Ishida","year":"2016","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.isci.2026.117775_bib22","article-title":"Treatment of rheumatoid arthritis with biologics may exacerbate HTLV-1-associated conditions: A case report","volume":"96","author":"Terada","year":"2017","journal-title":"Medicine (Baltim.)"},{"key":"10.1016\/j.isci.2026.117775_bib23","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1038\/s41586-024-07103-x","article-title":"Mechanisms of action and resistance in histone methylation-targeted therapy","volume":"627","author":"Yamagishi","year":"2024","journal-title":"Nature"},{"key":"10.1016\/j.isci.2026.117775_bib24","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2023.1175762","article-title":"EZH1\/2 dual inhibitors suppress HTLV-1-infected cell proliferation and hyperimmune response in HTLV-1-associated myelopathy","volume":"14","author":"Koseki","year":"2023","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.isci.2026.117775_bib25","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1182\/bloodadvances.2023011131","article-title":"Reprogramming of pyrimidine nucleotide metabolism supports vigorous cell proliferation of normal and malignant T cells","volume":"8","author":"Watanabe","year":"2024","journal-title":"Blood Adv."},{"key":"10.1016\/j.isci.2026.117775_bib26","doi-asserted-by":"crossref","first-page":"2148","DOI":"10.3389\/fmicb.2019.02148","article-title":"Safety of Infliximab for the Eye Under Human T-Cell Leukemia Virus Type 1 Infectious Conditions in vitro","volume":"10","author":"Uchida","year":"2019","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.isci.2026.117775_bib27","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1172\/JCI117735","article-title":"Immunopathological mechanisms of human T cell lymphotropic virus type 1 (HTLV-I) uveitis. Detection of HTLV-I-infected T cells in the eye and their constitutive cytokine production","volume":"95","author":"Sagawa","year":"1995","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.isci.2026.117775_bib28","doi-asserted-by":"crossref","first-page":"2321","DOI":"10.1016\/j.celrep.2019.10.083","article-title":"Targeting Excessive EZH1 and EZH2 Activities for Abnormal Histone Methylation and Transcription Network in Malignant Lymphomas","volume":"29","author":"Yamagishi","year":"2019","journal-title":"Cell Rep."},{"key":"10.1016\/j.isci.2026.117775_bib29","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.ccr.2011.12.015","article-title":"Polycomb-mediated loss of miR-31 activates NIK-dependent NF-\u03baB pathway in adult T cell leukemia and other cancers","volume":"21","author":"Yamagishi","year":"2012","journal-title":"Cancer Cell"},{"key":"10.1016\/j.isci.2026.117775_bib30","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1038\/nm.4036","article-title":"Targeting EZH2 in cancer","volume":"22","author":"Kim","year":"2016","journal-title":"Nat. Med."},{"key":"10.1016\/j.isci.2026.117775_bib31","doi-asserted-by":"crossref","first-page":"6051","DOI":"10.1038\/ncomms7051","article-title":"The epigenetic modifier EZH2 controls melanoma growth and metastasis through silencing of distinct tumour suppressors","volume":"6","author":"Zingg","year":"2015","journal-title":"Nat. Commun."},{"key":"10.1016\/j.isci.2026.117775_bib32","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1182\/bloodadvances.2022008362","article-title":"Dual targeting of aberrant DNA and histone methylation synergistically suppresses tumor cell growth in ATL","volume":"7","author":"Kurahashi","year":"2023","journal-title":"Blood Adv."},{"key":"10.1016\/j.isci.2026.117775_bib33","doi-asserted-by":"crossref","DOI":"10.3390\/v16101616","article-title":"Current State of Therapeutics for HTLV-1","volume":"16","author":"Wang","year":"2024","journal-title":"Viruses"},{"key":"10.1016\/j.isci.2026.117775_bib34","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1186\/1742-4690-5-76","article-title":"The HTLV-1 Tax interactome","volume":"5","author":"Boxus","year":"2008","journal-title":"Retrovirology"},{"key":"10.1016\/j.isci.2026.117775_bib35","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1182\/blood-2013-12-544106","article-title":"The polycomb repressive complex 2 governs life and death of peripheral T cells","volume":"124","author":"Zhang","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.isci.2026.117775_bib36","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1161067","article-title":"The multifaceted nature of IL-10: regulation, role in immunological homeostasis and its relevance to cancer, COVID-19 and post-COVID conditions","volume":"14","author":"Carlini","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.isci.2026.117775_bib37","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.3324\/haematol.2020.264523","article-title":"Loss of interleukin-10 activates innate immunity to eradicate adult T-cell leukemia-initiating cells","volume":"106","author":"El Hajj","year":"2021","journal-title":"Haematologica"},{"key":"10.1016\/j.isci.2026.117775_bib38","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1097\/ICO.0000000000000689","article-title":"Formation of Segmental Rounded Nodules During Infiltration of Adult T-Cell Leukemia Cells Into the Ocular Mucous Membrane","volume":"35","author":"Kamoi","year":"2016","journal-title":"Cornea"},{"key":"10.1016\/j.isci.2026.117775_bib39","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1007\/s12185-017-2293-2","article-title":"Adult T-cell leukemia cell-induced uveitis: rapid increase in adult T-cell leukemia cells disrupts the blood-ocular barrier","volume":"106","author":"Hirano","year":"2017","journal-title":"Int. J. Hematol."},{"key":"10.1016\/j.isci.2026.117775_bib40","doi-asserted-by":"crossref","first-page":"3240","DOI":"10.3389\/fmicb.2018.03240","article-title":"Adult T-Cell Leukemia\/Lymphoma-Related Ocular Manifestations: Analysis of the First Large-Scale Nationwide Survey","volume":"9","author":"Kamoi","year":"2018","journal-title":"Front. Microbiol."}],"container-title":["iScience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589004226031561?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589004226031561?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T10:11:07Z","timestamp":1794478267000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589004226031561"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":40,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["S2589004226031561"],"URL":"https:\/\/doi.org\/10.1016\/j.isci.2026.117775","relation":{},"ISSN":["2589-0042"],"issn-type":[{"value":"2589-0042","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dual impact of EZH1\/2-targeted therapy in HTLV-1-associated inflammation: Direct and indirect mechanisms","name":"articletitle","label":"Article Title"},{"value":"iScience","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.isci.2026.117775","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"117775"}}